Skip to main content
H.R. 5547 118th Congress House

Maintaining Investments in New Innovation Act

Official title: To amend title XI of the Social Security Act to protect access to genetically targeted technologies.

Introduced: March 19, 2024 See on congress.gov
Health GeneticsMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Sep 22, 2023
Referred to the Subcommittee on Health.
Sep 18, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 18, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 17, 2024

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Maintaining Investments in New Innovation Act

This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)

 Related & companion bills 1
  • S 476 Identical bill Maintaining Investments in New Innovation Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Lobbying activity 5

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • LMH STRATEGIC SOLUTIONS
    for IONIS PHARMACEUTICALS, INC. · California · 1st Quarter 2025 (Jan 1 - Mar 31)
  • HARMONY BIOSCIENCES
    for HARMONY BIOSCIENCES · Pennsylvania · 1st Quarter 2025 (Jan 1 - Mar 31)
  • TIBER CREEK HEALTH STRATEGIES, INC.
    for NOVARTIS · District of Columbia · 1st Quarter 2025 (Jan 1 - Mar 31)
  • FORBES-TATE
    for NOVARTIS, INC. · District of Columbia · 1st Quarter 2025 (Jan 1 - Mar 31)
  • FORBES-TATE
    for IONIS PHARMACEUTICAL, INC. · California · 1st Quarter 2025 (Jan 1 - Mar 31)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

 Cosponsors 28
All 28 Democratic 4 Republican 20
R
Calvert, Ken
California · Dec 5, 2024
 D
Morelle, Joseph D.
New York · Dec 5, 2024
 R
Hern, Kevin
Oklahoma · Oct 29, 2024
 R
Pfluger, August
Texas · Oct 29, 2024
 R
Dunn, Neal P.
Florida · Sep 10, 2024
 D
Gottheimer, Josh
New Jersey · Sep 10, 2024
 R
Tenney, Claudia
New York · Sep 10, 2024
Burgess, Michael
· Aug 27, 2024
 R
Smucker, Lloyd
Pennsylvania · Jun 14, 2024
 D
Cherfilus-McCormick, Sheila
Florida · May 23, 2024
 R
Kelly, Mike
Pennsylvania · May 23, 2024
 R
Carey, Mike
Ohio · May 15, 2024
 R
Van Duyne, Beth
Texas · May 15, 2024
 R
Buchanan, Vern
Florida · May 1, 2024
 R
Malliotakis, Nicole
New York · Apr 10, 2024
 R
Miller-Meeks, Mariannette
Iowa · Mar 21, 2024
 R
Meuser, Daniel
Pennsylvania · Mar 19, 2024
 R
Moore, Blake D.
Utah · Mar 19, 2024
 R
Smith, Adrian
Nebraska · Mar 19, 2024
 R
Harshbarger, Diana
Tennessee · Mar 1, 2024
 R
Allen, Rick W.
Georgia · Feb 23, 2024
Ferguson, A.
· Dec 11, 2023
 R
Hudson, Richard
North Carolina · Dec 6, 2023
Bucshon, Larry
· Nov 30, 2023
 R
Crenshaw, Dan
Texas · Nov 14, 2023
 D
Peters, Scott H.
California · Nov 1, 2023
 D
Davis, Donald G.
North Carolina · Sep 18, 2023
 R
Joyce, John
Pennsylvania · Sep 18, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5547: Maintaining Investments in New Innovation Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-5547/
MLA
"H.R. 5547: Maintaining Investments in New Innovation Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-5547/.
Bluebook (legal)
H.R. 5547, 118th Cong. (2026), https://openamerica.io/bill/118-HR-5547/.
Markdown link
[H.R. 5547: Maintaining Investments in New Innovation Act](https://openamerica.io/bill/118-HR-5547/)
Report a problem